Campbell, Douglas H. Oct. 26 [no year] [to S. Watson]

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-02
DOI
https://doi.org/10.5281/zenodo.16717902
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Campbell, Douglas H. Oct. 26 [no year] [to S. Watson]

Zenodo (CERN European Organization for Nuclear Research)
HER2/EGFR in Cancer Research
article

Campbell, Douglas H. Oct. 26 [no year] [to S. Watson]

article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Life in Land
Openalex Percentile: Top 41%
HER2/EGFR in Cancer Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Campbell, Douglas H. Oct. 26 [no year] [to S. Watson] · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS